静脉利多卡因在成人脊柱手术中的术式特异性效应:随机对照试验的系统评价与Meta分析
该系统评价与Meta分析纳入10项随机对照试验,评估围术期静脉利多卡因在成人脊柱手术中的镇痛与阿片节省效应。结果显示利多卡因可降低术后24小时疼痛强度(MD -0.83,95%CI -1.36至-0.30)和阿片消耗(MD -11.64 mg静脉吗啡当量),且镇痛效应因术式而异,在器械融合或复杂脊柱手术中有临床意义,在减压术中较小。
要点
- 围术期静脉利多卡因可降低成人脊柱手术后24小时疼痛强度和阿片消耗。
- 镇痛效应因术式而异:器械融合或复杂脊柱手术中MD -1.23,超过MCID 1.0分。
- 减压术中镇痛效应较小(MD -0.20),术式差异来自事后探索性分析,需谨慎解读。
核心结论
- 中等确定性证据表明围术期静脉利多卡因可减少成人脊柱手术后疼痛和阿片消耗。
- 镇痛获益呈现术式特异性,器械融合和复杂手术获益最大,但该差异来自事后探索性分析,应视为假设生成。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase、Web of Science和Cochrane Library从建库至2026年6月。
- 纳入10项随机对照试验,比较围术期静脉利多卡因输注与安慰剂或标准治疗在成人脊柱手术中的效果。
- 主要结局为术后24小时疼痛强度,次要结局包括阿片消耗、术后恶心呕吐和住院时间。
- 采用随机效应Meta分析、按术式的事后亚组分析和Meta回归。
主要发现
- 静脉利多卡因降低术后24小时疼痛(9项试验,655例患者;MD -0.83,95%CI -1.36至-0.30;p=0.002;I²=89%,95%CI 81%至93%;预测区间-2.69至1.02;中等确定性)。
- 静脉利多卡因降低阿片消耗(9项试验;MD -11.64 mg静脉吗啡当量;95%CI -16.14至-7.14;p<0.001)。
- 事后探索性分析显示镇痛效应因术式而异(亚组差异检验p=0.005):器械融合或复杂脊柱手术MD -1.23(95%CI -1.81至-0.64),超过最小临床重要差异1.0分;减压术MD -0.20(95%CI -0.61至0.21)。
- 基线疼痛严重程度解释约53%的组间异质性,利多卡因输注速率未改变治疗效果(p=0.97)。
- 术后恶心呕吐和住院时间未见显著效应。
临床怎么用
- 可考虑在器械融合或复杂成人脊柱手术中围术期使用静脉利多卡因以减轻术后疼痛和阿片消耗。
- 在单纯减压术中,静脉利多卡因的镇痛获益较小,应结合患者情况个体化决策。
- 术式特异性获益来自事后探索性分析,临床应用中需结合更多证据谨慎判断。
局限性
- 术式特异性差异来自事后探索性分析,应视为假设生成而非确证性结论。
- 疼痛结局异质性较高(I²=89%),预测区间跨越零,提示效应在不同研究间不一致。
- 术后恶心呕吐和住院时间未见显著效应,相关证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Perioperative intravenous lidocaine infusion has been proposed as an opioid-sparing analgesic adjunct in spine surgery, but previous meta-analyses pooled heterogeneous procedures and may have obscured procedure-specific treatment effects. We evaluated the analgesic and opioid-sparing effects of perioperative intravenous lidocaine in adult spine surgery and whether efficacy differs by procedure type. METHODS: We searched PubMed, Embase, Web of Science, and the Cochrane Library from inception through June 2026 for randomized controlled trials comparing perioperative intravenous lidocaine infusion with placebo or standard care in adults undergoing spine surgery. The primary outcome was postoperative pain intensity at 24 hours. Secondary outcomes were opioid consumption, postoperative nausea and vomiting (PONV), and hospital length of stay (LOS). Random-effects meta-analyses, a post hoc subgroup analysis by procedure type, and meta-regression were performed. RESULTS: 10 randomized trials were included. Intravenous lidocaine reduced postoperative pain at 24 hours (9 trials, 655 patients; mean difference (MD), -0.83; 95% CI -1.36 to -0.30; p=0.002; I²=89%, 95% CI 81% to 93%; prediction interval, -2.69 to 1.02; moderate certainty) and opioid consumption (9 trials; MD, -11.64 mg intravenous morphine equivalents; 95% CI -16.14 to -7.14; p<0.001). In a post hoc exploratory analysis, the analgesic effect differed by procedure type (test for subgroup differences, p=0.005): the reduction was clinically meaningful after instrumented fusion or complex spine surgery (MD, -1.23; 95% CI -1.81 to -0.64), exceeding the minimal clinically important difference of 1.0 point, but minimal after decompression (MD, -0.20; 95% CI -0.61 to 0.21). Baseline pain severity explained approximately 53% of between-study heterogeneity, whereas lidocaine infusion rate did not modify the treatment effect (p=0.97). No significant effects were observed for PONV or LOS. CONCLUSIONS: There is moderate-certainty evidence that perioperative intravenous lidocaine reduces postoperative pain and opioid consumption after adult spine surgery. Its analgesic benefit appeared procedure-specific, with the greatest benefit after instrumented fusion and complex procedures; this difference emerged from a post hoc, exploratory analysis and should be regarded as hypothesis-generating.
引用
- A Felippe V, D A Bersot C, L Gonzalez G, et al. Procedure-specific effects of intravenous lidocaine in adult spine surgery: a systematic review and meta-analysis of randomized controlled trials. Reg Anesth Pain Med. 2026. PMID: 42692530. doi:10.1136/rapm-2026-108266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。